CEACAM5 and disease of peritoneum: Additional pathologic and clinical features, including carcinoembryonic antigen (CEA) level, extent of peritoneal disease (peritoneal carcinomatosis index/PCI), prior cytoreductive surgery, recent systemic therapy within 3 months prior to surgical resection, and best response to therapy are included in Table 1.